--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
SECURITIES AND EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 30, 2004
GERON CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-20859 75-2287752
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification Number)
230 Constitution Drive 94025
Menlo Park, California (Zip Code)
(Address of principal executive offices)
(650) 473-7700
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On June 30, 2004, Geron Corporation, a Delaware corporation (the "Company"), and
Kyowa Hakko Kogyo Co., Ltd. announced that Kyowa Hakko has returned Asian
territory development and marketing rights for Geron's telomerase inhibitors.
The Company's press release announcing the conclusion of the collaboration is
filed as an exhibit to this Current Report on Form 8-K. The summary description
of the transaction and the press release are qualified in their entirety by
reference to the document filed as an exhibit hereto.
Item 7. Exhibits.
Exhibits
--------
99.1 Press release dated June 30, 2004
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GERON CORPORATION
Date: June 30, 2004 By: /s/ William D. Stempel
----------------------------
Name: William D. Stempel
Title: Vice President and
General Counsel
EXHIBIT INDEX
Exhibits
--------
99.1 Press release dated June 30, 2004